NRC Health
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -16.5% | +22.6% | +4.6% | +41.9% | +2.7% | -0.7% | +14.0% | -21.7% | +5.1% | -9.2% | -23.6% | |
| – | +8.0% | +2.8% | +8.5% | +19.1% | +1.4% | +35.5% | -15.1% | -17.2% | +11.8% | +2.1% | +26.6% | |
| – | +86.4% | +39.5% | -4.4% | -17.9% | -19.2% | -44.4% | -8.4% | +92.6% | -22.1% | -69.6% | +1,066.2% | |
| – | -127.1% | – | -47.4% | +111.1% | -18.4% | -68.5% | -10.8% | -104.5% | – | – | – | |
| – | -84.8% | -205.7% | – | – | -57.5% | -848.7% | – | -282.0% | – | +274.8% | -76.2% | |
| – | +17.9% | +35.2% | +21.3% | +23.9% | -22.0% | -14.4% | +38.4% | +78.4% | +60.4% | -2.1% | -30.7% | |
| – | -76.8% | +182.8% | +63.1% | -2.4% | -22.0% | -20.0% | +128.6% | +15.5% | +60.4% | +28.5% | -47.2% | |
| – | +0.0% | +184.0% | -40.9% | 0.0% | +85.7% | -66.4% | -12.9% | +128.9% | +73.5% | -68.5% | -4.1% | |
| – | +407.2% | -88.4% | +717.6% | +4,238.7% | -98.5% | – | -338.9% | +566.7% | -30.8% | +62.0% | -34.8% | |
| – | +3.7% | -8.3% | +12.5% | – | -110.2% | -3.0% | +13.6% | +7.4% | – | +83.3% | -37.5% | |
| – | +875.1% | +92.7% | -35.0% | +158.1% | -33.3% | -57.3% | +17.2% | +206.0% | -26.8% | -58.8% | -5.5% | |
| – | -88.3% | -533.9% | – | -1,370.0% | – | +3,925.3% | -7.1% | -249.1% | – | – | – | |
| – | -20.1% | +20.7% | +1.8% | +45.6% | +7.0% | +1.1% | +11.4% | -35.3% | -15.5% | -14.1% | -17.9% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.